SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹539 Cr | ₹646 Cr | ₹559 Cr | ₹537 Cr | ₹513 Cr |
What is the latest Total Current Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹539 Cr |
Mar2024 | ₹646 Cr |
Mar2023 | ₹559 Cr |
Mar2022 | ₹537 Cr |
Mar2021 | ₹513 Cr |
How is Total Current Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹539 Cr | -16.58 | |
Mar2024 | ₹646 Cr | 15.53 | |
Mar2023 | ₹559 Cr | 3.98 | |
Mar2022 | ₹537 Cr | 4.72 | |
Mar2021 | ₹513 Cr | - |
Compare Total Current Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹4,395.3 Cr | -0.7% | -7.2% | 26.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 1.2% | -4.2% | -5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3% | -9.1% | 31.5% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 4.1% | 5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.1% | 4.3% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.7% | 0.1% | -7.4% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | -0.7% |
-7.2% |
26.8% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses